Australia TGA ARTG record

Pharmaceutical management support software

Australia TGA ARTG Registered Device · Pfizer Australia Pty Ltd · Pfizer Inc · Class I · Started June 27, 2018

Good Name: Pfizer Australia Pty Ltd - Pharmaceutical management support software

Device classification

Risk Class: Class I
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: June 27, 2018
Effective Date: June 27, 2018

Sponsor

Name: Pfizer Australia Pty Ltd

Manufacturer

Name: Pfizer Inc
Country: United States of America
Address: 100 Route 206 North, Peapack, New Jersey, 07977

Intended purpose

Clopine Central is a web-based application intended for the remote monitoring of Agranulocytosis or Neutropenia, via completion of regular blood testing, as reported by medical practitioners for patients affected by Treatment Resistant Schizophrenia.

About this record

Access comprehensive regulatory information for Pharmaceutical management support software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Pfizer Australia Pty Ltd, manufactured by Pfizer Inc in United States of America. The device registration started on June 27, 2018.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.